User Fee Cover Sheet: FDA Form 3397

Known as: 1.1.3, Form FDA 3397: User Fee Cover Sheet 
A form designed to provide the minimum necessary information to determine whether a fee is required for review of an application, to determine the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Biomass pelleting process strongly depends on a number of variables hard to be simultaneously controlled. This paper suggests a… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
...................................................................................................................................... x Vorbemerkung ............................................................................................................................. xi 1 Hintergrund .......................................................................................................................... 1 1.1 Versorgungsforschung ............................................................................................................. 1 1.1.1 Definition, Ziele und Aufgaben der Versorgungsforschung ............................................... 1 1.1.2 Methoden der Versorgungsforschung ............................................................................... 3 1.1.3 Versorgungsforschung in Deutschland ............................................................................... 4 1.2 Public Health-Last kardiovaskulärer Erkrankungen................................................................. 4 1.2.1 Koronare Herzkrankheit / Akuter Myokardinfarkt ............................................................. 5 1.2.2 Herzinsuffizienz .................................................................................................................. 6 1.2.3 Vorhofflimmern .................................................................................................................. 7 1.2.4 Zukünftige Entwicklungen von Morbiditätslast und Versorgungsbedarf ........................... 8 1.3 Datenquellen für die Versorgungsforschung zu kardiovaskulären Erkrankungen ................ 11 1.3.1 Primärdatenerhebungen und Registerdaten ................................................................... 11 1.3.2 GKV-Routinedaten ............................................................................................................ 11 1.4 Ziele der Arbeit ...................................................................................................................... 17 2 Kurzdarstellung der Ergebnisse der Einzelarbeiten ............................................................... 18 2.1 German Pharmacoepidemiological Research Database ....................................................... 18 2.2 Validierung mortalitätsassoziierter Informationen in GKV-Routinedaten ............................ 18 2.2.1 Vergleich von Mortalitätsindikatoren mit einer externen Datenquelle ........................... 18 2.2.2 Personenindividuelles Record Linkage mit dem Goldstandard ........................................ 19 2.3 Evaluation von Methoden zur Verknüpfung von GKV-Routinedaten mit Daten eines Krankenhausinformationssystems ....................................................................................... 19 
Is this relevant?
2011
2011
Economic constraints to the professional design practice limit customized solutions to the very wealthy, and thus most of the… (More)
  • figure 1-1
  • figure 1-2
  • figure 1-4
  • figure 1-6
  • figure 1-7
Is this relevant?
Review
2010
Review
2010
ab Affiliation cs All fields metadata Author(s) au Catalog number ca CODEN cn Conference date cy Document title ti Editor(s) au… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2010
Review
2010
  • THOMAS MUSYOKI
  • 2010
.......................................................................................................................................... viii CHAPTER ONE: INTRODUCTION .................................................................................................. 1 1.1 Background of the Study .............................................................................................................................. 1 1.1.1 Organizational Performance ................................................................................................................. 3 1.1.2 Soft Drink Industry in Kenya ................................................................................................................. 4 1.1.3 Coca Cola Company Limited ................................................................................................................ 4 1.1.3 Coca Cola (Kenya) Limited .................................................................................................................. 5 1.2 Statement of the Problem ........................................................................................................................ 6 1.3 Objectives of the Study ................................................................................................................................. 7 1.4 Value of the Study ........................................................................................................................................ 7 CHAPTER TWO: LITERATURE REVIEW ...................................................................................... 9 2. 
  • figure 4.1
  • table 4.1
  • figure 4.2
  • table 4.2
  • figure 4.3
Is this relevant?
2008
2005
2005
  • Daftar Pustaka, Peraturan Kepala Badan, +5 authors dalam Produk Pangan
  • 2005
CONTENTS 1.0 Introduction 1.1 Definitions 1.1.1 Validation 1.1.2 Method of analysis 1.1.3 Performance characteristics of a method… (More)
  • figure 2
Is this relevant?
2004
2004
The XSophe-Sophe-XeprView computer simulation software suite enables scientists to easily determine spin Hamiltonian parameters… (More)
Is this relevant?